|
KR20080082597A
(ko)
*
|
2005-07-28 |
2008-09-11 |
글로벌 리서치 테크놀로지스, 엘엘씨 |
공기로부터 이산화탄소의 제거
|
|
US8334257B2
(en)
|
2005-12-20 |
2012-12-18 |
Duke University |
Methods and compositions for delivering active agents with enhanced pharmacological properties
|
|
US20130172274A1
(en)
|
2005-12-20 |
2013-07-04 |
Duke University |
Methods and compositions for delivering active agents with enhanced pharmacological properties
|
|
US8841255B2
(en)
|
2005-12-20 |
2014-09-23 |
Duke University |
Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
|
|
US7709227B2
(en)
|
2006-01-04 |
2010-05-04 |
Phasebio Pharmaceuticals, Inc. |
Multimeric ELP fusion constructs
|
|
EP2004813B1
(en)
|
2006-04-03 |
2015-06-03 |
Promega Corporation |
Permuted and nonpermuted luciferase biosensors binding cyclic nucleotides
|
|
JP6110591B2
(ja)
|
2008-05-19 |
2017-04-05 |
プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ |
ｃＡＭＰのためのルシフェラーゼバイオセンサー
|
|
EP3412300A1
(en)
*
|
2008-06-27 |
2018-12-12 |
Duke University |
Therapeutic agents comprising elastin-like peptides
|
|
EP2307540B1
(en)
|
2008-07-07 |
2017-04-19 |
Oxford Nanopore Technologies Limited |
Enzyme-pore constructs
|
|
JP2011527191A
(ja)
|
2008-07-07 |
2011-10-27 |
オックスフォード ナノポア テクノロジーズ リミテッド |
塩基検出細孔
|
|
GB0820927D0
(en)
|
2008-11-14 |
2008-12-24 |
Isis Innovation |
Method
|
|
CN101418290A
(zh)
*
|
2008-12-02 |
2009-04-29 |
中山大学 |
一种高效的elp融合蛋白酶及其制备和应用
|
|
WO2010085768A1
(en)
|
2009-01-26 |
2010-07-29 |
Nanoink,Inc. |
Large area, homogeneous array fabbrication including leveling with use of bright spots
|
|
WO2010086622A1
(en)
|
2009-01-30 |
2010-08-05 |
Oxford Nanopore Technologies Limited |
Adaptors for nucleic acid constructs in transmembrane sequencing
|
|
BRPI1007215A2
(pt)
*
|
2009-01-30 |
2017-08-29 |
Oxford Nanopore Tech Ltd |
Método de acoplamento covalente de duas ou mais porções, primeira e segunda porções, primeiro porção acoplada a uma segunda porção, par de primeiro e segundo ligantes, e, uso de um par de ligantes.
|
|
GB0905140D0
(en)
|
2009-03-25 |
2009-05-06 |
Isis Innovation |
Method
|
|
US20100316623A1
(en)
*
|
2009-04-23 |
2010-12-16 |
Andrew Turner |
Phenylalanine hydroxylase fusion protein and methods for treating phenylketonuria
|
|
WO2011020091A1
(en)
|
2009-08-14 |
2011-02-17 |
Phasebio Pharmaceuticals, Inc. |
Modified vasoactive intestinal peptides
|
|
US8940868B2
(en)
*
|
2009-10-08 |
2015-01-27 |
The General Hospital Corporation |
Elastin based growth factor delivery platform for wound healing and regeneration
|
|
US9035028B2
(en)
*
|
2010-03-10 |
2015-05-19 |
Emory University |
Temperature sensitive conjugate compositions
|
|
EP2990479B1
(en)
|
2010-05-11 |
2019-03-27 |
Promega Corporation |
Mutant protease biosensors with enhanced detection characteristics
|
|
US9290794B2
(en)
|
2010-05-11 |
2016-03-22 |
Promega Corporation |
Mutant protease biosensors with enhanced detection characteristics
|
|
CN101955960B
(zh)
*
|
2010-08-03 |
2012-05-23 |
中山大学 |
一种利用类弹性蛋白标签纯化重组乳糖酶的方法
|
|
KR101939420B1
(ko)
|
2011-02-11 |
2019-01-16 |
옥스포드 나노포어 테크놀로지즈 리미티드 |
돌연변이체 세공
|
|
US20120213781A1
(en)
|
2011-02-11 |
2012-08-23 |
Zyngenia, Inc. |
Monovalent and Multivalent Multispecific Complexes and Uses Thereof
|
|
EP2717902B1
(en)
|
2011-06-06 |
2018-01-24 |
Phasebio Pharmaceuticals, Inc. |
Use of modified vasoactive intestinal peptides in the treatment of hypertension
|
|
CN102241747A
(zh)
*
|
2011-06-17 |
2011-11-16 |
李立文 |
类人弹性蛋白及其生产方法
|
|
BR112014001699A2
(pt)
|
2011-07-25 |
2017-06-13 |
Oxford Nanopore Tech Ltd |
método para sequenciar de um polinucleotídeo alvo de filamento duplo, kit, métodos para preparar um polinucleotídeo alvo de filamento duplo para sequenciamento e para sequenciar um polinucleotídeo alvo de filamento duplo, e, aparelho
|
|
US9102763B2
(en)
|
2011-07-26 |
2015-08-11 |
University Of Southern California |
Controlled release of ocular biopharmaceuticals using bioresponsive protein polymers
|
|
CN104023784B
(zh)
*
|
2011-08-24 |
2018-05-25 |
费斯生物制药公司 |
供持续释放的活性剂制剂
|
|
WO2013120022A2
(en)
*
|
2012-02-08 |
2013-08-15 |
Seneb Biosciences, Inc. |
Treatment of hypoglycemia
|
|
US20130210747A1
(en)
|
2012-02-13 |
2013-08-15 |
University Of Southern California |
Methods and Therapeutics Comprising Ligand-Targeted ELPs
|
|
JP6157877B2
(ja)
*
|
2012-02-28 |
2017-07-05 |
三洋化成工業株式会社 |
組織再生用ゲル、組織再生用タンパク質溶液及び組織再生用ゲルの製造方法
|
|
CA2869546C
(en)
|
2012-04-10 |
2020-07-21 |
Oxford Nanopore Technologies Limited |
Mutant lysenin pores
|
|
EP2875154B1
(en)
|
2012-07-19 |
2017-08-23 |
Oxford Nanopore Technologies Limited |
SSB method for characterising a nucleic acid
|
|
WO2014026054A2
(en)
|
2012-08-10 |
2014-02-13 |
University Of Southern California |
CD20 scFv-ELPs METHODS AND THERAPEUTICS
|
|
WO2014028776A1
(en)
*
|
2012-08-15 |
2014-02-20 |
Zyngenia, Inc. |
Monovalent and multivalent multispecific complexes and uses thereof
|
|
JP2016505627A
(ja)
*
|
2013-01-15 |
2016-02-25 |
フェーズバイオ ファーマシューティカルズ，インコーポレイテッド |
治療剤、組成物、および血糖コントロールのための方法
|
|
GB201314695D0
(en)
|
2013-08-16 |
2013-10-02 |
Oxford Nanopore Tech Ltd |
Method
|
|
AU2014224432B2
(en)
|
2013-03-08 |
2019-10-24 |
Oxford Nanopore Technologies Limited |
Enzyme stalling method
|
|
GB201313477D0
(en)
|
2013-07-29 |
2013-09-11 |
Univ Leuven Kath |
Nanopore biosensors for detection of proteins and nucleic acids
|
|
EP3052125B1
(en)
*
|
2013-10-01 |
2020-09-30 |
University of Mississippi Medical Center |
Elastin-like polypeptide coupled to therapeutic agent for delivery during pregnancy
|
|
WO2015120091A1
(en)
*
|
2014-02-04 |
2015-08-13 |
Duke University |
Systems and devices for protease detection based on engineered polymers and biopolymers and methods of use
|
|
GB201403096D0
(en)
|
2014-02-21 |
2014-04-09 |
Oxford Nanopore Tech Ltd |
Sample preparation method
|
|
ES2879804T3
(es)
|
2014-04-21 |
2021-11-23 |
D&D Pharmatech Inc |
Agonistas del receptor de TRAIL para el tratamiento de enfermedades fibróticas
|
|
EP3137490B1
(en)
|
2014-05-02 |
2021-01-27 |
Oxford Nanopore Technologies Limited |
Mutant pores
|
|
US11052132B2
(en)
|
2014-05-08 |
2021-07-06 |
Phasebio Pharmaceuticals, Inc. |
Methods and compositions for treating cystic fibrosis
|
|
WO2016034591A2
(en)
|
2014-09-01 |
2016-03-10 |
Vib Vzw |
Mutant pores
|
|
EP3204511B1
(en)
|
2014-10-07 |
2021-07-28 |
Oxford Nanopore Technologies Limited |
Mutant pores
|
|
GB201418159D0
(en)
|
2014-10-14 |
2014-11-26 |
Oxford Nanopore Tech Ltd |
Method
|
|
AU2015349743B2
(en)
|
2014-11-21 |
2021-06-10 |
Immunoforge Co., Ltd. |
ELP fusion proteins for controlled and sustained release
|
|
CA2970478A1
(en)
|
2014-12-10 |
2016-06-16 |
S-Aima Holding Company, Llc |
Generation of hemoglobin-based oxygen carriers using elastin-like polypeptides
|
|
CA2976038A1
(en)
|
2015-02-09 |
2016-08-18 |
Phasebio Pharmaceuticals, Inc. |
Methods and compositions for treating muscle disease and disorders
|
|
US10639371B2
(en)
*
|
2015-07-29 |
2020-05-05 |
University Of Delaware |
Thermoresponsive bioconjugates and their controlled delivery of cargo
|
|
CN106632682A
(zh)
*
|
2015-08-04 |
2017-05-10 |
清华大学 |
融合蛋白ifn-elp及其应用
|
|
CA2994279A1
(en)
|
2015-08-04 |
2017-02-09 |
Duke University |
Genetically encoded intrinsically disordered stealth polymers for delivery and methods of using same
|
|
KR101759122B1
(ko)
|
2015-08-07 |
2017-07-18 |
계명대학교 산학협력단 |
오렉신 a를 함유하는 당뇨병 치료용 약학 조성물
|
|
JP6797203B2
(ja)
|
2015-12-17 |
2020-12-09 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
デスレセプターアゴニストによる全身性硬化症の改善
|
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
|
US11059870B2
(en)
|
2016-03-14 |
2021-07-13 |
Industry-University Cooperation Foundation Hanyang University Erica Campus |
Polypeptides with phase transition, triblock polypeptides of the polypeptide-calmodulin-polypeptide with multi-stimuli responsiveness, hydrogel of the triblock polypeptides, and its uses
|
|
KR102028931B1
(ko)
*
|
2016-03-24 |
2019-10-08 |
한양대학교 에리카산학협력단 |
지능형 약물 전달을 위한 다중 자극 반응성을 지닌 칼모듈린-엘라스틴 이중 블럭 폴리펩타이드의 동적 나노 전달체 및 제조방법
|
|
KR102508650B1
(ko)
|
2016-04-07 |
2023-03-13 |
더 존스 홉킨스 유니버시티 |
사멸 수용체 작용제로써 췌장암 및 통증을 치료하기 위한 조성물 및 방법
|
|
WO2017192449A1
(en)
*
|
2016-05-06 |
2017-11-09 |
Phasebio Pharmaceuticals, Inc. |
Elp fusion proteins for controlled and sustained release
|
|
GB201609220D0
(en)
|
2016-05-25 |
2016-07-06 |
Oxford Nanopore Tech Ltd |
Method
|
|
WO2017210476A1
(en)
|
2016-06-01 |
2017-12-07 |
Duke University |
Nonfouling biosensors
|
|
CN107459580A
(zh)
*
|
2016-06-06 |
2017-12-12 |
易金阳 |
一种利用酵母菌表达含有穿膜肽的寡肽‑1（egf）创新制备工艺
|
|
WO2018053201A1
(en)
|
2016-09-14 |
2018-03-22 |
Duke University |
Triblock polypeptide-based nanoparticles for the delivery of hydrophilic drugs
|
|
JP2020500150A
(ja)
|
2016-09-23 |
2020-01-09 |
デューク ユニバーシティ |
下限臨界溶液温度挙動を有する非反復かつ非構造的ポリペプチド
|
|
CN106519040B
(zh)
*
|
2016-11-02 |
2020-03-27 |
南京大学 |
一种含肿瘤坏死因子相关凋亡诱导配体的融合蛋白和其制备方法及由该蛋白自组装的纳米粒
|
|
US11648200B2
(en)
|
2017-01-12 |
2023-05-16 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
|
WO2018213320A1
(en)
|
2017-05-15 |
2018-11-22 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
|
KR101955366B1
(ko)
*
|
2017-06-02 |
2019-03-07 |
인제대학교 산학협력단 |
인터페론 베타-엘라스틴 재조합 단백질 및 이의 생산방법
|
|
US11680083B2
(en)
|
2017-06-30 |
2023-06-20 |
Duke University |
Order and disorder as a design principle for stimuli-responsive biopolymer networks
|
|
JP7074995B2
(ja)
*
|
2017-10-13 |
2022-05-25 |
林兼産業株式会社 |
線維芽細胞増殖促進剤及び線維芽細胞におけるエラスチン産生促進剤
|
|
WO2019147954A1
(en)
|
2018-01-26 |
2019-08-01 |
Duke University |
Albumin binding peptide-drug (aibiped) conjugates and methods of making and using same
|
|
CN108531492A
(zh)
*
|
2018-04-23 |
2018-09-14 |
内蒙古农业大学 |
利用类弹性蛋白elp构建活性绵羊β-防御素sbd-1体外表达的方法
|
|
US12257308B2
(en)
|
2018-04-30 |
2025-03-25 |
Duke University |
Stimuli-responsive PEG-like polymer-based drug delivery platform
|
|
GB201807793D0
(en)
|
2018-05-14 |
2018-06-27 |
Oxford Nanopore Tech Ltd |
Method
|
|
US11649275B2
(en)
|
2018-08-02 |
2023-05-16 |
Duke University |
Dual agonist fusion proteins
|
|
EP3837276A4
(en)
|
2018-08-16 |
2022-05-18 |
Isolere Bio, Inc. |
Genetically encoded polypeptide for affinity capture and purification of biologics
|
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
|
WO2021030196A1
(en)
*
|
2019-08-09 |
2021-02-18 |
Phasebio Pharmaceuticals, Inc. |
Elp fusion proteins comprising parathyroid hormone for controlled and sustained release
|
|
US20230099707A1
(en)
*
|
2020-02-19 |
2023-03-30 |
Isolere Bio, Inc. |
Protein-based purification matrices and methods of using the same
|
|
WO2021202546A1
(en)
|
2020-03-31 |
2021-10-07 |
Cyclerion Therapeutics, Inc. |
Early drug interventions to reduce covid-19 related respiratory distress, need for ventilator assistance and death
|
|
US11767353B2
(en)
|
2020-06-05 |
2023-09-26 |
Theraly Fibrosis, Inc. |
Trail compositions with reduced immunogenicity
|
|
KR102687389B1
(ko)
*
|
2020-08-25 |
2024-07-25 |
한양대학교 에리카산학협력단 |
자극 반응성 및 표면 부착성을 가진 점착성 엘라스틴 및 서커린 기반 다중 블록 코폴리펩타이드, 그의 자가조립 구조체 및 주사형 하이드로겔의 생접착제 응용
|
|
KR20230125179A
(ko)
|
2020-12-23 |
2023-08-29 |
재즈 파마슈티칼즈 아일랜드 리미티드 |
전하-차폐 융합 단백질의 정제 방법
|
|
JP2024509742A
(ja)
*
|
2021-02-19 |
2024-03-05 |
ドナルドソン カンパニー，インコーポレイティド |
相挙動を有するタンパク質を含む融合タンパク質
|
|
EP4530300A4
(en)
*
|
2022-05-23 |
2026-03-25 |
Univ Fudan |
Clover Factor 2 Fusion Protein/Interferon Alpha2 and its Use in the Prevention and Treatment of Viral Infectious Diseases
|
|
CN115724915B
(zh)
*
|
2022-08-17 |
2025-08-12 |
上普博源（北京）生物科技有限公司 |
类弹性蛋白多肽粘合剂及其制备方法与应用
|
|
CN117777303A
(zh)
*
|
2022-09-27 |
2024-03-29 |
北京大学 |
一种高亲和力pd1蛋白偶联物及其应用
|
|
JP2025541413A
(ja)
*
|
2022-12-27 |
2025-12-18 |
ネクスセラ カンパニー リミテッド |
エラスチン類似ポリペプチド基盤の組換えタンパク質の作製及びその動物細胞発現プラットフォーム
|
|
WO2025076213A1
(en)
*
|
2023-10-04 |
2025-04-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Isothermally phase-separable elastin-like polypeptides, compositions, and methods of use thereof
|
|
WO2025100511A1
(ja)
*
|
2023-11-10 |
2025-05-15 |
地方独立行政法人神奈川県立産業技術総合研究所 |
融合ペプチド
|